Contents

Mounjaro vs Ozempic: Which One Is Better for Weight Loss, Diabetes & Side Effects?

Written by: Dr. Darren Wang (LCP, MMC No. 68601) | Medically Reviewed by: Dr. Jeff Khor (LCP, MMC No. 66113)

Ozempic vs Mounjaro treatment are the two names you hear most when people talk about weight loss injections and type 2 diabetes. Both are weekly pens. Both curb appetite. But they’re not the same drug, and picking the wrong one for your body can mean more side effects, less results, or wasted RM.

So which one actually works better? Let’s break it down drug to drug — no fluff, no bias.

Important: Both Mounjaro and Ozempic are prescription-only medications. This is general information, not medical advice. Talk to your doctor before starting or switching.

Mounjaro vs Ozempic: The Quick Summary

Feature

Mounjaro (Tirzepatide)

Ozempic (Semaglutide)

Approved For

Type 2 diabetes

Type 2 diabetes. Wegovy = same drug for weight loss

Drug Class

Dual GIP + GLP-1 receptor agonist

GLP-1 receptor agonist only

Dose Range

2.5mg to 15mg weekly

0.25mg to 2mg weekly

Weight Loss Trial Avg

Up to 22.5% at 72 weeks, 15mg

Up to 15% at 68 weeks, 2.4mg Wegovy

Blood Sugar Reduction

Lowers A1c by 1.8% – 2.4%

Lowers A1c by 1.4% – 1.8%

Cost in Malaysia

RM4,800 – RM7,200/month

RM800 – RM1,200/month

Main Advantage

Stronger for weight loss + A1c

Cheaper, more available, longer track record

 

If you want maximum weight loss and don’t mind the price, Mounjaro usually wins. If you want proven diabetes control, lower cost, or can’t tolerate strong appetite suppression, Ozempic is often the better start.

How They Work: The Science Made Simple

Both drugs mimic gut hormones you release after eating. That’s why you feel full faster and longer.

Ozempic = GLP-1 only. It slows stomach emptying, tells your pancreas to release insulin when blood sugar is high, and hits appetite centers in your brain.

Mounjaro = GLP-1 + GIP. It does everything Ozempic does, plus activates GIP receptors. GIP also improves insulin sensitivity and may reduce nausea at higher doses. Think of Mounjaro as pulling two levers instead of one.

That extra lever is why Mounjaro beat Ozempic head-to-head in trials for both A1c and weight.

Mounjaro vs Ozempic for Weight Loss: Which Is Stronger?

No contest in the data so far.

Head-to-Head Trial: SURPASS-2

In people with type 2 diabetes over 40 weeks:

  • Ozempic 1mg: 6.2kg average loss
  • Mounjaro 5mg: 7.8kg
  • Mounjaro 10mg: 10.3kg
  • Mounjaro 15mg: 12.4kg

Separate Weight Loss Trials

  • Wegovy = Ozempic’s high-dose version for weight loss: 15% average body weight loss at 68 weeks
  • Mounjaro in non-diabetics: 22.5% average loss at 72 weeks on 15mg

Real life varies. Some people are “non-responders” to one drug but lose well on the other. But if we’re talking averages, Mounjaro is stronger. You’ll also notice food noise shuts off more completely for most Mounjaro users.

Mounjaro vs Ozempic for Type 2 Diabetes

Both are excellent for lowering A1c and fasting glucose.

In trials, Mounjaro lowered A1c by 0.4% more than Ozempic 1mg on average. More people on Mounjaro got their A1c under 7% and under 5.7%.

Ozempic has one big advantage: cardiovascular data. Ozempic is proven to reduce risk of heart attack, stroke, and death in people with type 2 diabetes + heart disease. Mounjaro’s heart trials are still ongoing. If you have heart disease, many doctors pick Ozempic first for that reason.

Side Effects: Which One Is Easier to Tolerate?

Both cause the same main side effects because they work similarly: nausea, vomiting, diarrhea, constipation, burping, fatigue, and reduced appetite.

Ozempic: Nausea tends to peak when you jump doses. Some people get “Ozempic face” from rapid weight loss.

Mounjaro: Because it’s stronger, nausea and diarrhea can hit harder in the first 8 weeks. But many people report less nausea than Ozempic at high doses, possibly due to the GIP component. Burping and acid reflux are common on both.

Tips to reduce side effects on either drug:

  1. Start low, go slow. Don’t rush dose increases.
  2. Eat small, protein-first meals. Stop before you’re full.
  3. Avoid fried, greasy, or high-sugar foods.
  4. Stay hydrated. Dehydration makes nausea worse.
  5. Inject in thigh vs stomach if you get site nausea.

Serious risks for both: pancreatitis, gallbladder issues, kidney injury from dehydration, and a boxed warning for thyroid C-cell tumors seen in rats. These are rare. If you have MEN 2 or a history of medullary thyroid cancer, you can’t take either.

Dosing Schedule Compared

Both are once-weekly injections. You start low and titrate up every 4 weeks based on tolerance.

Ozempic dosing: 0.25mg → 0.5mg → 1mg → 2mg
Mounjaro dosing: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg

You stay at the lowest dose that controls your blood sugar or appetite. More is not always better if side effects are bad.

Cost & Availability in Malaysia: 2026

This is where Ozempic wins for most people.

Ozempic 1mg pen: RM800 – RM1,200 per pen = RM800 – RM1,200/month
Mounjaro 5mg-15mg: RM1,200 – RM1,800 per pen = RM4,800 – RM7,200/month

Ozempic is available at most private hospitals, clinics, and some pharmacies with a prescription. Mounjaro supply in Malaysia is still limited and sells out fast. You’ll usually only find it at specialist endocrinology or aesthetic clinics in KL, PJ, Penang, and JB.

Insurance: Neither is typically covered for weight loss. For diabetes, Ozempic has better chance of partial coverage. Mounjaro usually 100% out-of-pocket.

Who Should Pick Mounjaro?

Choose Mounjaro if:

  1. Your main goal is maximum weight loss and budget isn’t a barrier.
  2. You tried Ozempic/Wegovy and plateaued early.
  3. Your A1c is still high on Ozempic 2mg.
  4. You can tolerate stronger appetite suppression.

Who Should Pick Ozempic?

Choose Ozempic if:

  1. You have type 2 diabetes + history of heart disease or stroke.
  2. Cost is a major factor. Ozempic is 5-6x cheaper in Malaysia.
  3. You want a drug with 6+ years of real-world safety data.
  4. You’re new to GLP-1s and want to start with the “standard” option.
  5. You only need moderate weight loss, e.g. 10-15%.

Can You Switch From Ozempic to Mounjaro?

Yes. Lots of people do when weight loss stalls. General rule: wait 7 days after your last Ozempic dose, then start Mounjaro at 2.5mg, even if you were on Ozempic 2mg. Don’t jump straight to 5mg — the side effects can be rough.

Your doctor will guide the switch. Don’t take both at the same time.

What Happens When You Stop?

With both drugs, appetite comes back and blood sugar can rise again. Weight regain is common unless you’ve locked in new eating and exercise habits. This is why doctors view them as long-term therapies, similar to blood pressure meds.

The Bottom Line: Mounjaro or Ozempic?

For weight loss: Mounjaro wins on average, but costs much more.
For diabetes + heart disease: Ozempic wins due to proven cardiovascular benefits.
For budget + access: Ozempic wins in Malaysia right now.
For side effects: It’s personal. Some tolerate Ozempic better, some tolerate Mounjaro better.

There’s no “best” for everyone. The best one is the one you can afford, tolerate, and stay on long enough to see results. Start with your doctor, not TikTok.

Medical Disclaimer

This content is for educational purposes only and does not constitute medical advice. All aesthetic treatments in Malaysia must be performed by LCP-certified doctors under Ministry of Health (MOH) guidelines. Results vary individually — consult a qualified medical professional for a personalised diagnosis and treatment plan.

Pricing displayed is indicative only and subject to change. Final treatment costs are determined following a personalised in-clinic consultation. Contact Her Clinic directly for current pricing and available treatment packages.

Dr. Jeff Khor, LCP-certified aesthetic physician in Malaysia

Dr. Jeff Khor
LCP-Certified Aesthetic Physician · MMC Reg: 66113 · Her Clinic, Malaysia

Dr. Jeff Khor is a highly distinguished aesthetic physician with over a decade of clinical experience, specializing in non-surgical facial rejuvenation, Ultherapy Prime, skin boosters, injectables, and advanced skin physiology. He holds an MD from Volgograd State Medical University and the Letter of Credentialing and Privileging (LCP) from the Ministry of Health Malaysia — the gold-standard credential required for high-level medical aesthetic practice. Dr. Khor is fully registered with the Malaysian Medical Council (MMC No. 66113) and serves as Her Clinic’s Medical Reviewer, ensuring all published patient guidance is clinically accurate and aligned with current Ministry of Health guidelines and international aesthetic best practices.

View full profile & credentials →